Friday, February, 10, 2012

Tarceva

Featured Article

Adding Celebrex to the current lung cancer treatment Tarceva increased response rates in patients by 33 percent in a new study at the University of California. Researchers suggest that the addition of Celebrex to Tarceva may help patients overcome their resistance to Tarceva and thus help inhibit their tumors' growth.

Read more

More information on "Tarceva"

From Our Experts

See more SharePosts »

From Our Sources

More on Prostate »